Content Loading
Skip to main content

Managing Conflicts of Interest


Historically, the Federal government has proposed and implemented guidelines, policies, rules and regulations which establish standards for the conduct of higher education personnel and programs funded with public funds. One of the recent issues to affect most universities pursuing sponsored research projects is conflict of interest.

Several federal agencies have issued guidelines that grantees must abide by if external funding is to be utilized. These guidelines have shaped University policy and procedures regarding financial conflicts of interest in relationship to sponsored activities involving research, education, and services. Their purpose is to protect the credibility and integrity of Southwestern Oklahoma State University’s faculty and staff in order that the public trust and confidence in all sponsored activities is ensured.

These regulations require that principal investigators disclose to a designated university official certain significant financial interests that would reasonably appear to be affected by the proposed sponsored activity. These disclosures must be submitted at or before the time of submission of the proposed application for funding. Based on the disclosed information, the university is held responsible for determining whether a conflict of interest exists.

A potential conflict of interest exists when there is a divergence between an individual’s private interests and his or her professional obligations to the university, such that an independent observer might reasonably question whether the individual’s professional actions or decisions are determined by considerations of personal gain, financial or otherwise. An actual conflict of interest depends on the situation and not on the character or actions of the individual.

For purposes of this policy, a conflict of interest exists when the university reasonably determines that a significant financial interest could directly or indirectly and significantly affect the design, conduct, or reporting of the sponsored activities.

When a conflict is identified, the university is required to develop and implement a plan to manage, reduce, or eliminate the conflict of interest prior to any expenditure of funds on the grant, contract, or cooperative agreement.

The university must also comply with certain reporting requirements to the sponsoring agency related to the existence of conflicts and those conflicts which cannot be resolved, and maintain records of financial disclosures and actions taken as part of the project’s history in compliance with 2 CFR Part 200. In addition, the guidelines require that all financial disclosures be updated during the award period, either on an annual basis or as new significant financial interests are discovered. The final component of the required policy is to establish adequate enforcement mechanisms and to provide sanctions where appropriate.


The term investigator means the principal investigator, co-principal investigator, and any other person at the institution who is responsible for the design, conduct, or reporting of a sponsored activity funded or proposed for funding by an external sponsor.

Sponsored activities include research, education, service, and training activities funded by an external sponsor.

A significant financial interest is defined as anything of monetary value received directly or indirectly from a sponsor in excess of $10,000, or more than a 5% ownership interest for the investigator, his or her spouse, and dependent children combined.

The monetary value can include, but is not limited to:

  1. Salary, or other payments for services such as consulting fee and honoraria;
  2. Equity interests such as stocks, stock options, or other ownership interests; or
  3. Intellectual property rights such as patents, copyrights, and royalties from such

Significant financial interests do not include:

  1. Salaries, royalties, or other compensation from the applicant’s institution
  2. Ownership interests in the applicant’s institution, if the institution is an applicant under the Small Business Innovation Research (SBIR) program or Small Business Technology Transfer Program for NSF,
  3. Income for seminars, lectures, or teaching engagements sponsored by public or nonprofit entities
  4. Income from service on advisory committees or review panels for public or nonprofit entities
  5. An equity interest that, when aggregated for the investigator and the investigator’s spouse and dependent children, meets both of the following tests: does not exceed $10,000 in value as determined through reference to public prices or other reasonable measures of fair market value, and does not represent more than a 5% ownership interest in any single entity
  6. Salary, royalties, or other payments that when aggregated for the investigator and the investigators spouse and dependent children over the next 12 months are not expected to exceed $10,000 and does not represent more than a 5% ownership interest in a single entity.


It is the policy of SWOSU that the investigator(s) must disclose any significant financial interests that would reasonably appear to directly or indirectly and significantly affect the design, conduct, or reporting of sponsored activities funded or proposed for funding by an external sponsoring agency.

Training Requirements

In accordance with the 2011 Revised Financial Conflict of Interest (FCOI) Regulation, Promoting Objectivity in Research (42 CFR Part 50 Subpart F), the following provides training guidelines to insure compliance with this regulation for U.S. Public Health Service (PHS) related grants and contracts, including those from the National Institutes of Health (NIH).

Each investigator as defined in the University FCOI policy must complete mandatory FCOI training (link provided below) prior to engaging in research related to any PHS-funded grant or contract (including those from NIH) and at least every FOUR YEARS, and immediately under the circumstances such as:

  • Institutional FCOI policies change in a manner that affects investigator requirements;
  • An investigator is new to an institution; or
  • An institution finds an investigator noncompliant with its FCOI policy or management

To meet this requirement, investigators will complete the Conflict of Interest Tutorial located on the NIH website. This tutorial can be found at

At the end of the tutorial is a certificate of completion. Each investigator will print one copy, sign and date it, and send it to the Office of Sponsored Programs (OSP). A copy of this certificate MUST be on file in OSP before expenditures can be made from any PHS-related grants and contracts, including those from the NIH.

The institutional FCOI policy related to sponsored programs can be found Here. Other institutional conflict of interest information can be obtained from the SWOSU Human Resources office.

This training will be required of investigators applying for and receiving PHS-related grants and contracts, including those from NIH, as of August 25, 2012.

Disclosure Requirements

Per 42 CFR 50.604(b) and 42 CFR 50.604(e) (1)-(3) Investigators must file disclosures of significant financial interests and any required documentation to the designated university official prior to submitting proposals to an external sponsoring agency.

A Potential Conflict of Interest Form has been developed for this purpose. This disclosure will be treated as confidential information and used only for compliance with Federal regulations regarding conflicts of interest.

Records of investigator(s) financial disclosures, any required documentation, and actions taken to manage conflicts of interest shall be retained for 3 years following the termination or completion of the award to which they relate, or the resolution of any government action involving those records, whichever is longer.

Disclosure Review

Disclosures shall be reviewed by the designated university official prior to submitting the proposal or in cases where the grant or contract has already been awarded prior to initiating expenditures from grants, contracts, or cooperative agreements awarded by the sponsoring agency. The designated university official will determine whether a conflict of interest exists and how such conflicts may be managed, reduced, or eliminated (42 CFR 50.604(d)).

In cases where conflicts of interest are identified, the designated university official will have the responsibility for developing a plan, acceptable to both the investigator and the university, to manage, reduce, or eliminate the conflict of interest. No funds will be expended prior to the development of this plan. For new conflicts that arise during an active grant or contract, an acceptable plan must be developed within 30 days.

NOTE: An SFI is related to PHS/NIH-funded research when the Institution though it’s designated official(s), reasonably determines that the SFI:

  • could be affected by the PHS/NIH-funded research
  • is in an entity whose financial interest could be affected by the research.

The investigator may be involved in making the determination of whether the SFI is related to the PHS/NIH- funded research. An FCOI exists when the Institution, through its designated official(s), reasonably determines that the SFI could directly and significantly affect the design, conduct, or reporting of the PHS/NIH-funded research.


Examples of conditions or restrictions that may be imposed to manage, reduce or eliminate a potential conflict of interest include but are not limited to:

  1. Public disclosure of significant financial interests;
  2. Monitoring of sponsored activities by independent reviewers;
  3. Modification of the sponsored activity plan;
  4. Disqualification from participation in all or a portion of the sponsored activity;
  5. Divestiture of significant financial interests; or
  6. Severance of relationships that create actual or potential conflicts of

If the designated university official determines that imposing the above referenced conditions or restrictions would either be ineffective or inequitable, and that the potential negative impacts that may arise from a significant financial interest are outweighed by interests of scientific progress, technology transfer, or the public health and welfare, then the designated university official may recommend that, to the extent permitted by Federal regulations, the sponsoring activity go forward without imposing such conditions or restrictions.

The approved resolution plan shall be documented in writing detailing the conditions or restrictions imposed upon the investigator(s) in the conduct of the sponsored activity or in the relationship with the business enterprise or entity.

In accordance with specific agency regulations, the designated university official will notify the agency, in writing, of all identified conflicts of interest, including those which the university is unable to satisfactorily manage, reduce, or eliminate. Additional reports or information required by the agency involved will be provided.

Prior to the Institution’s expenditure of funds, designated official(s) will

  • Review all Investigator SFI disclosures
  • Determine if any SFIs relate to PHS/NIH-funded research
  • Determine if an FCOI exists (e.g., the SFI that could directly and significantly affect the design, conduct, or reporting of the NIH-funded research)
  • Develop and implement a management plan to manage the FCOI(s) (45 CFR 50.605(a)(1))

An Investigator who is new to participating in the research project or when an existing Investigator discloses a new SFI, the institution’s designated official(s) shall within sixty (60) days review disclosures of SFIs, determine whether the SFI is related to PHS/NIH-funded research; determine whether an FCOI exists; and, if so, implement, on at least an interim basis, a management plan that shall specify the actions that have been, and will be, taken to manage such FCOI. (42 CFR 50.605(a)(2))

Whenever the Institution identifies an SFI that was not disclosed timely by an Investigator or, for whatever reason, was not previously reviewed by the Institution during an ongoing PHS/NIH-funded research project (e.g., was not timely reviewed or reported by a subrecipient), the designated official(s) shall within sixty (60) days review disclosures of SFIs, determine whether the SFI is related to PHS/NIH-funded research; determine whether an FCOI exists; and if so, implement, at least on an interim basis, a management plan that specifies the actions that have been, and will be taken to manage such FCOI going forward. 42 CFR 50.605(a)(3) and (i) – (iii)

The designated official shall take such actions as necessary to manage FCOIs, including any financial conflicts of a subrecipient Investigator, if applicable, and monitor Investigator compliance with management plans until completion of the project. 42 CFR 50.604 (g); 42 CFR 50.605(a)(4)

Reporting Significant Financial Interests to NIH

Initial, annual (i.e., ongoing) and revised FCOI reports, including all required information defined in the regulation (42 CFR 50.604(h); 42 CFR 50.605(b))and/or NIH’s FAQ H.5, will be sent to the NIH via the eRA Commons FCOI Module for the Institution and its subrecipients, if applicable, as required by the regulation and as stated below:

  • Prior to the expenditure of funds
  • Within sixty (60) days of identification for an Investigator who is newly participating in the project
  • Within sixty (60) days for new, or newly identified, FCOIs for existing investigators
  • At least annually (at the same time as when the Institution is required
  • to submit the annual progress report, multi-year progress report, if applicable, or at time of extension). The annual report will provide the status of the FCOI and any changes to the management plan, if applicable, until the completion of the project.
  • After a retrospective review to update a previously submitted report, if new information is discovered following completion of the review. 42 CFR 50.605(a)(3)(iii)

NIH will be promptly notified if bias is found with the design, conduct or reporting of PHS/NIH-funded research and will include the requirement to submit a Mitigation Report to explain what action(s) have been or will be taken to mitigate the effects of the bias in accordance with the regulation. 42 CFR 50.605(a)(3)(iii)

NIH will be promptly notified if an Investigator fails to comply with the Institution’s FCOI policy or the FCOI management plan appears to have biased the design, conduct, or reporting of the PHS/NIH-funded research. 42 CFR 50.606(a)

Maintenance of Records

All FCOI-related records relating to all Investigator disclosures of financial interests and the Institution’s review of, and response, to such disclosures (whether or not a disclosure resulted in the Institution’s determination of a financial conflict of interest) and all actions under the Institution’s policy or retrospective review, if applicable, will be maintained (42 CFR 50.604(i)):

  • For at least three (3) years from the date the final expenditures report is submitted to the PHS (NIH).
  • Or, where applicable, from other dates specified in 45 CFR 75.361 for different situations.


The designated university official shall be responsible for determining and implementing sanctions on investigators who have violated this policy in terms of a conflict of interest resolution. The investigator shall be notified, in writing, of the recommended sanctions within 30 days. If the sanctions involve a recommendation of termination of employment, the university academic termination procedures will be invoked. The university must take action appropriate for the seriousness of the violation, including, but not limited to, one or more of the following, subject to existing university policies for institutional disciplinary action (42 CFR 50.604(j)):

  1. Termination;
  2. Removal from particular activity;
  3. Special monitoring of future work;
  4. Letter of reprimand; or
  5. Probation for specified period with conditions

A retrospective review will be completed within 120 days of the Institution’s determination of noncompliance when an SFI is not disclosed timely or previously reviewed or whenever an FCOI is not identified or managed in a timely manner, including

  • Failure by the Investigator to disclose a significant financial interest that is determined by the Institution to constitute a financial conflict of interest;
  • Failure by the Institution to review or manage such a financial conflict of interest;
  • Failure by the Investigator to comply with the financial conflict of interest management plan (42 CFR 605(a)(3)).

The retrospective review will include the following key elements:

  • Project Number
  • Project Title
  • PD/PI or contact PD/PI if multiple PD/PI model is used
  • Name of the Investigator with the FCOI
  • Name of the entity with which the Investigator has an FCOI
  • Reasons for the retrospective review
  • Detailed methodology of the review process, composition of the review panel, documentation reviewed)
  • Findings of the review
  • Conclusions of the review

42 CFR 50.605(a)(3)(ii)(B)

In any case in which the Department of Health and Human Services determines that a PHS/NIH-funded research project of clinical research whose purpose is to evaluate the safety or effectiveness of a drug, medical device, or treatment has been designed, conducted, or reported by an Investigator with an FCOI that was not managed or reported by the Institution as required by the regulation, the Institution shall require the Investigator involved to:

  • Disclose the FCOI in each public presentation of the results of the research, and
  • To request an addendum to previously published presentations. 42 CFR 50.606(c)

The university shall follow Federal regulations regarding the notification of the sponsoring agency in the event an investigator has failed to comply with this policy. The sponsor may take its own action as it deems appropriate, including the suspension of funding for the investigator until the matter is resolved.

Individuals may appeal the judgment and or the sanction. A written statement of the grounds for the appeal must be submitted to the President of the university within 30 days of written notification of the sanctions. Grounds for appeal include, but are not limited to, previously unconsidered material evidence, sanctions not commensurate with the finding, and failure to follow the prescribed process. Upon receipt of a written appeal, the President will evaluate the evidence and make a determination. The President will open an investigation if the previously unconsidered material evidence so warrants and may open an investigation if circumstances so dictate. The President’s decision will be conveyed to all involved in a timely fashion, but must be conveyed within 30 days. In the case of termination, the appropriate university policies on termination for cause shall be followed.

Subrecipient Requirements

Where applicable, written agreements will include a statement whether the subrecipient will follow the FCOI policy of the awardee Institution or the FCOI policy of the subrecipient. Where applicable, a certification will be obtained from the subrecipient that its FCOI policy complies with the regulation. The subrecipient agreement will require the subrecipient to report identified FCOIs for its Investigators in a time frame that allows the awardee institution to report identified FCOIs to the NIH as required by the regulation. Alternatively, if applicable, the written agreement will include a requirement to solicit and review subrecipient Investigator disclosures that enable the awardee institution to identify, manage and report identified FCOIs to the NIH. 42 CFR 50.604(c)(1)(i)-(iii)


The principal investigator must verify that he or she has disclosed all potential conflicts of interest and all other pertinent information by signing a certification statement. The statement is as follows:

"I certify that I have read and understand the Southwestern Oklahoma State University’s Policy on Conflict of Interest. I have made all financial disclosures, and that I will comply with the Policy and any conditions or restrictions imposed by the University to manage, reduce, or eliminate actual or potential conflicts of interest."

The designated university official must also certify, on behalf of the university, that the institution has implemented and is enforcing a written policy on conflicts of interest. The statement for the designated university official is as follows:

As the designated university official, I certify that all financial disclosures required by the conflict of interest policy were made; and that actual or potential conflicts of interests, if any, were, or prior to funding the award, satisfactorily managed, reduced or eliminated in accordance with the institution’s conflict of interest policy or disclosed to the agency involved.

The certification and disclosure form can be found at HERE.

Public Accessibility

The Institution’s FCOI policy will be publicly accessible on SWOSU Research website with other research compliance policies. 42 CFR 50.604(a)

Information will be made publicly available concerning identified FCOIs held by senior/key personnel prior to the expenditure of funds.

The publicly accessible information will

  • Include the minimum elements as provided in the regulation
  • Be made available within five (5) business days of a written request
  • Be updated annually
  • Be updated within sixty (60) days of a newly identified FCOI
  • Remain available for three (3) years from the date the information was most recently updated
  • 42 CFR 50.605(a)(5)(i)-(iv)